<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02823002</url>
  </required_header>
  <id_info>
    <org_study_id>STU00202894</org_study_id>
    <nct_id>NCT02823002</nct_id>
  </id_info>
  <brief_title>Pain Perception: Lidocaine Rate/Temp/Buffer</brief_title>
  <official_title>The Impact of Anesthetic Injection Rate, Temperature and Buffering on Pain Perception During Dermatologic Procedures: a Multicenter, Single-blinded Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will collect data from multiple academic institutions. The primary objective for
      part A of this study is to determine the impact of anesthetic injection rate and temperature
      on pain perception during dermatologic procedures, and the objective for the part B of this
      study is to determine if buffering of the anesthetic solution alters pain perception.

      This study is a pilot study designed to determine feasibility of these procedures.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain on a Visual Analog Scale (VAS)</measure>
    <time_frame>intraoperative</time_frame>
    <description>Subjects will rate the pain VAS score immediately after the needle is withdrawn. They will be asked to rate the pain of the injection of the solution. VAS pain scale is rated on a 10 cm scale with 0 cm being no pain and 10 cm being extremely painful.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Slow, Room Temperature</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, subject will be randomized to receive an injection of lidocaine that is slow at room temperature, rapid at room temperature, slow at warm temperature, or rapid at warm temperature.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rapid, Room Temperature</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, subject will be randomized to receive an injection of lidocaine that is slow at room temperature, rapid at room temperature, slow at warm temperature, or rapid at warm temperature.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Slow, Warmed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, subject will be randomized to receive an injection of lidocaine that is slow at room temperature, rapid at room temperature, slow at warm temperature, or rapid at warm temperature.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rapid, Warmed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part A, subject will be randomized to receive an injection of lidocaine that is slow at room temperature, rapid at room temperature, slow at warm temperature, or rapid at warm temperature.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Buffered</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Part B, subject will be randomized to receive an injection of lidocaine that is buffered or non-buffered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Buffered</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In Part B, subject will be randomized to receive an injection of lidocaine that is buffered or non-buffered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Slow, Room Temperature Injection</intervention_name>
    <description>The room temperature local anesthetic agent will be administered by slow infiltration.</description>
    <arm_group_label>Slow, Room Temperature</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rapid, Room Temperature Injection</intervention_name>
    <description>The room temperature local anesthetic agent will be administered by rapid infiltration.</description>
    <arm_group_label>Rapid, Room Temperature</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Slow, Warm Temperature Injection</intervention_name>
    <description>The warmed local anesthetic agent will be administered by slow infiltration.</description>
    <arm_group_label>Slow, Warmed</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rapid, Warm Temperature Injection</intervention_name>
    <description>The warmed local anesthetic agent will be administered by rapid infiltration.</description>
    <arm_group_label>Rapid, Warmed</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Buffered Injection</intervention_name>
    <description>One side of the body will be randomized to receive an injection of the buffered agent, while the contralateral side will be assigned to receive an injection of the unbuffered anesthetic agent.</description>
    <arm_group_label>Buffered</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-Buffered Injection</intervention_name>
    <description>One side of the body will be randomized to receive an injection of the buffered agent, while the contralateral side will be assigned to receive an injection of the unbuffered anesthetic agent.</description>
    <arm_group_label>Non-Buffered</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Injectable lidocaine solution (Lidocaine Hydrochloride and Epinephrine)</description>
    <arm_group_label>Slow, Room Temperature</arm_group_label>
    <arm_group_label>Rapid, Room Temperature</arm_group_label>
    <arm_group_label>Slow, Warmed</arm_group_label>
    <arm_group_label>Rapid, Warmed</arm_group_label>
    <arm_group_label>Buffered</arm_group_label>
    <arm_group_label>Non-Buffered</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buffer</intervention_name>
    <description>Sodium Bicarbonate</description>
    <arm_group_label>Slow, Room Temperature</arm_group_label>
    <arm_group_label>Rapid, Room Temperature</arm_group_label>
    <arm_group_label>Slow, Warmed</arm_group_label>
    <arm_group_label>Rapid, Warmed</arm_group_label>
    <arm_group_label>Buffered</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who are undergoing dermatologic procedures.

          -  Subjects ages 18-89 year old.

          -  The subjects have the willingness and the ability to understand and provide informed
             consent and communicate with the investigator.

        Exclusion Criteria:

          -  Subjects who are allergic to lidocaine.

          -  History of bleeding tendency or coagulopathy.

          -  Pregnant or lactating.

          -  Active skin disease or skin infection in the treatment area.

          -  Unable to understand the protocol or give informed consent.

          -  Any other condition, in the professional opinion of the investigator, that would
             potentially affect response or participation in the clinical study, or would pose as
             an unacceptable risk to the subject.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murad Alam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University Department of Dermatology</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2016</study_first_submitted>
  <study_first_submitted_qc>June 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2016</study_first_posted>
  <last_update_submitted>February 20, 2018</last_update_submitted>
  <last_update_submitted_qc>February 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Murad Alam</investigator_full_name>
    <investigator_title>Professor in Dermatology, Otolaryngology-Head and Neck Surgery, and Surgery</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

